Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million - Following pre-NDA meeting with FDA, on track to submit TransCon CNP ...

Unions that purport to represent workers have not lifted a finger, even as thousands of workers continue to be fired across ...

Under Nevada law, because the Reverse Split was approved by the shareholders of the Company on February 14, 2025, and in accordance with NRS Section 78.2055, the Company may effect the Reverse Split ...

North America Revenue Up 13.1% Year-Over-Year. Core adjusted EBITDA for the third fiscal quarter of 2025 was $1.50 million, compared to ($0.02) with the same period in 2024.

In the past 20 years, the Howard Frankland has become ever more essential, linking not just two downtowns but two growing ...

In a suit filed Friday, Uber Technologies accused its food delivery rival DoorDash of anti-competitive business practices that cost Uber millions. Ex-OpenAI employee Suchir Balaji died by suicide ...